Synthesis of Fatty Acid Amides of Catechol Metabolites that Exhibit Antiobesity Properties

A series of fatty acid amides of 3,4‐methylenedioxymethamphetamine (MDMA) catechol metabolites were synthesized in order to evaluate their biological activities. Upon administration, all synthesized compounds resulted in negative modulation of food intake in rats. The most active compounds have affi...

Full description

Saved in:
Bibliographic Details
Published inChemMedChem Vol. 5; no. 10; pp. 1781 - 1787
Main Authors Almeida, Bruno, Joglar, Jesús, Luque Rojas, María Jesús, Decara, Juan Manuel, Bermúdez-Silva, Francisco Javier, Macias-González, Manuel, Fitó, Montserrat, Romero-Cuevas, Miguel, Farré, Magí, Covas, María Isabel, Rodríguez de Fonseca, Fernando, de la Torre, Rafael
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag 04.10.2010
WILEY‐VCH Verlag
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A series of fatty acid amides of 3,4‐methylenedioxymethamphetamine (MDMA) catechol metabolites were synthesized in order to evaluate their biological activities. Upon administration, all synthesized compounds resulted in negative modulation of food intake in rats. The most active compounds have affinity for the CB1 receptor and/or PPAR‐α; part of their biological activity may be caused by these double interactions. Curbing the appetite: Fatty acid amides of 3,4‐methylenedioxymethamphetamine catechol metabolites were synthesized, and their biological activities were evaluated. All the compounds caused rats to decrease their food intake. The most active compounds show affinity for the CB1 receptor and/or PPAR‐α, so part of their biological activity may be caused by these double interactions.
Bibliography:European Union FP7 - No. HEALTH-F2-2008-223713
Fundació La Marató de TV3 - No. 2006-061230
European Union Program of High Level Scholarships for Latin America - No. E06D101051BR
Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y la Nutrición
ArticleID:CMDC201000161
ark:/67375/WNG-PJ608W4F-C
Generalitat de Catalunya - No. AGAUR 2009 SGR 718
Consejería de Economía, Innovación y Ciencia, Junta de Andalucía - No. PI-0232/2008
Red de Trastornos Adictivos - No. FIS-TARD06/001/0026; No. RD06/001/0000
istex:D205EF7BEA47A81C49BEA6C2BB8D5186825A4970
Instituto de Salud Carlos III - Fondo de Investigación Sanitaria FIS - No. FIS CP04/0039; No. PI 07/1226; No. PI 07/0880
UE-FEDER - No. CVI-1038
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1860-7179
1860-7187
DOI:10.1002/cmdc.201000161